|
Are stricter regulatory procedures hampering growth in the pharma industry?
| Yes |
77% |
| NO |
8% |
| Don't Know |
15% |
 |
|
|
|
|
|
|
|
17 September, 2013
|
|
|
Emerging Pharma Markets: The Inconvenient Truth
Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets, writes William Looney ...Read more |
Why the Smartwatch Should Make Time for Health
The smartwatch is stepping tentatively into the dynamic mobile communications arena. But it has a long way to go before it becomes a disruptive technology. Key to its adoption may be its approach to digital health, writes Peter Houston ... Read more
|
Crisis Preparedness in an ‘Always On’ Digital World
The first 120 minutes of a crisis can determine the public’s perception of an organization. And in today’s digital world, companies are more at risk than ever to viral attacks from unexpected sources. For the pharma industry, in particular, being prepared to respond and shape the conversation around your brand and company is critical, write Laura Schoen and Stacey Bernstein ... Read more
|
Pharm Exec Global Digest Market Access Special
In the new issue: Develop a Market Access Roadmap; Embed Market Access in Your Organizational Culture; Initiating Early Access Programs in Europe; and More! ... Read more
|
|
| Sciformix |
 Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations.  Read more |
|
|
|
|
|
|
|
|
